Introduction
A significant association between the presence of clinical vascular disease and a reduced hypoglycaemic effect of intravenous insulin has been reported previously in a group of longterm insulin-dependent diabetics (Martin and Stocks, 1968) . We report here a similar association in maturity-onset nonketotic diabetics not receiving insulin.
Material and Methods
Twenty-seven diabetics of maturity-onset type were studied the only criteria for selection were a duration of diabetes mellitus exceeding 10 years, without any evidence of ketosis, the co-operation of the patients, and the availability of adequate diabetic records for at least five years. Their ages ranged from 45 to 78 years, and duration of diabetes from 10 to 25 years. Only one patient exceeded her ideal body weight by more than 20 %.
Eight patients had required short courses of insulin therapy in the past, but none had received insulin for at least five years previous to the study. Two patients were controlled by diet alone; the remainder were taking oral hypoglycaemic drugs.
All attended as outpatients, having fasted overnight and omitted their morning hypoglycaemic therapy. Blood samples for plasma glucose and insulin were taken via an indwelling needle in the resting state, and 5, 10, 15, 20, 30, 45, and 60 minutes after the intravenous injection of 0-1 units/kg. of glucagon-free beef insulin.
Blood glucose was determined by AutoAnalyzer, and plasma insulin levels by the dextran-coated charcoal radioimmunoassay (Pearson, Fullerton, Martin, and Melick, 1968 ; Stocks, Pearson, and Odom, 1968) . Insulin sensitivity was expressed as the glucose assimilation index, an expression of the maximum percentage fall of blood glucose per minute after insulin (Norgaard and Thaysen, 1929) . Reasons for the choice of this method of expression have been discussed elsewhere (Martin and Stocks, 1967 Snedecor (1956) .
Results
The glucose assimilation index varied from 1-0 to 3 6 (mean 2-18) (Table I) , and, as can be seen in Fig. 1 , this fell between the mean value of 1-44 obtained in insulin-dependent juvenileonset diabetics and that of 2 75 found in normal subjects. (P<0 01). An attempt was made to assess the success of control of the diabetes retrospectively from clinical records as follows: good control=no glycosuria, all blood sugars <180 mg./100 ml.; fair control=usually no glycosuria, blood sugars <250 mg./ 100 ml. ; poor control=frequent glycosuria, blood sugars sometimes >250 mg./100 ml. In this way the control of 11 cases was classified as good, 11 as fair, and 5 as poor. Insulin insensitivity and vascular disease, particularly atherosclerosis, occurred more often in those patients who were poorly controlled.
Plasma cholesterol (range 118-329 mg./100 ml.) and triglycerides (range 71-190 mg./100 ml.) were both normal in the great majority of cases, and were not related to either the glucose assimilation index or vascular disease.
The half-time of disappearance of insulin from the circulation was determined in 22 patients and varied from 4 0 to 10 0 minutes (mean 644+17 minutes). There was no apparent relation between the half-time of disappearance of insulin and the age of the patients nor the duration of diabetes. Also there was no relation with the glucose assimilation index, or with the presence of atherosclerosis or microangiopathy.
Discussion
In this series 23 of 27 maturity-onset diabetics had a glucose assimilation index after intravenous insulin within the normal range, with a mean value of 218. This is lower than that of normal patients who have a mean of 2 75, but much higher than the mean glucose assimilation index of 144 found in 51 insulin-dependent diabetics (Martin and Stocks, 1968) . As the glucose assimilation index is reproducible it is probably a valid criterion to use in the definition of carbohydrate metabolism in diabetes. The degree of hypoglycaemic effectiveness of intravenous insulin was found to be inversely proportional to the severity of clinical atherosclerosis and microangiopathy. We believe that, despite the lack of precision possible in quantitating vascular disease, the degree of correlation between insulin insensitivity and vascular disease is such as to suggest a real relationship which is very similar to that reported previously for long-term insulin-dependent diabetics (Martin and Stocks, 1968) . The difference in insulin sensitivity between the insulindependent and maturity-onset diabetic groups may be related to the presence of insulin antibodies in the former causing a pronounced reduction in the acute hypoglycaemic effect of insulin. Several of the patients in the present series had received short courses of insulin many years previously, but none had detectable insulin antibodies. A similar spectrum of insulin sensitivity has been found in patients studied many years after receiving insulin therapy for schizophrenia, who also had no detectable insulin antibodies at the time of study (Martin and Alford, unpublished) .
A history of good control of diabetes in these maturity-onset diabetics was found to be associated with both a high glucose assimilation index and a relative absence of vascular disease. This association was not found in our earlier study of juvenileonset diabetics, where fluctuations of blood sugar are such as to make the degree of control almost impossible to assess. The present findings lend support to the contention of Joslin (1946) and his followers (Wilson, Root, and Marble, 1951 ) that good control of diabetes is importan. in the prevention of vascular disease.
Whether insensitivity to insulin precedes the vascular changes and in some way predisposes to them or whether vascular disease decreases the biological effectiveness of insulin remains unknown. Butterfield, Garratt, and Whichelow (1963) have shown that there is a decreased loss of "3'1-labelled insulin from the circulation of diabetics compared with non-diabetic subjects, but they did not attempt to relate this change to the presence of vascular disease. In the present series there was no tendency for immunoreactive insulin to disappear from the circulation more slowly in those patients with obvious vascular disease, though the mean time of disappearance was slower than that in non-diabetic subjects, a finding which supports the previous report by Stimmler (1967) . This would suggest that there was no barrier to the passage of insulin out of the circulation owing to vascular disease, but it cannot be regarded as being conclusive because of the importance of hepatic removal of insulin in determining the acute disappearance from the circulation (Kaplan and Madison, 1959) . On the other hand, there is some evidence that insulin insensitivity may precede vascular change, as 12 out of 25 diabetic patients studied within a month of diagnosis showed evidence of insulin insensitivity with a glucose assimilation index of less than 1-5. The possibility that there is a circulating insulin antagonist, either in plasma or at a tissue level, has been debated since the division of diabetics into so-called insulin-sensitive and insensitive types by Himsworth (1936) . The recent finding that a peptide fragment of growth hormone has an inhibitory effect on insulin-like activity at the glyceraldehyde dehydrogenase step (Bornstein, Krahl, Marshall, Gould, and Armstrong, 1968 ) is of great interest. It seems possible that an excess of such an inhibitor could provide an explanation of the early occurrence of insulin insensitivity in recently diagnosed diabetics. So far, however, this activity has been demonstrated only in extracted pituitary tissue, and has not been convincingly shown to occur in plasma or to be related to insulin insensitivity.
A possible sequence of events suggested by the above findings is that insensitivity to insulin present from the outset of diabetes may allow hyperglycaemia (and thus poor control) and cause glucose metabolism to be directed along non-insulin-dependent pathways, giving rise among other things to an increased production of glucosamine and mucopolysaccharides (Spiro, 1963) . These could be important in accelerating -the development of diabetic vascular disease.
A prospective study to determine the time relationship between insulin insensitivity and vascular disease is in progress. If this supports the above hypothesis the insulin sensitivity test could be used early in the course of diabetes to help define a group of patients at greater risk of developing atherosclerosis and microangiopathy.
